Market Highlights
There are various diseases that have their roots in genetics such as cancer, diabetes, Alzheimer’s, arthritis, heart disease, etc. To discover viable treatment for these diseases, researchers are looking to discern how genes work. The next-generation sequencing market has been gaining impetus due to the fact that next-generation sequencing is integral to the field of genomics. The NGS technologies are implemented for several applications, including whole-genome sequencing, de novo assembly sequencing, resequencing, and transcriptome sequencing at the DNA or RNA level. The successful application of next-generation sequencing can lead to predicting genes, protein-coding regions, and pathways.
Illumina, Helicos Biosciences, Thermo Fisher Scientific, Roche, Pacific Bioscience, ABI Life Technologies, and Oxford Nanopore are some of the companies that are implementing different NGS technologies which in turn will augment global next-generation sequencing market share is estimated to reach at a CAGR of 18.05% over the forecast period and USD 20,347.45 Million by 2025.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6354
Segmentation
The Next Generation Sequencing Market has been classified by Technology, Service and Product, Application, and End-User.
By technology, the next-generation sequencing market has been segmented as whole-genome sequencing, methyl sequencing, whole-exome sequencing, targeted resequencing, CHIP sequencing, RNA sequencing, and de novo sequencing.
By service & product, the next-generation sequencing market has been segmented as consumables, sample preparation, sequencing services, and platforms and services for platforms.
By application, the NGS market has been segmented as genetic screening, drug discovery, diagnostics, agriculture and animal research, and others.
End-users segmentation of the next generation sequencing market includes academic institutes and research centers, pharmaceutical and biotechnology companies, hospitals and clinics, and other end-users.
Regional Analysis
Owing to the rising number of funds being granted for research into genomics and initiatives adopted by the government to rein in cases of genetically occurring diseases and demand to improve the healthcare sector is estimated to augment the growth of the next-generation sequencing market in North America. Increased competition among market players as well as acquisitions and mergers are expected to drive the growth of the market in the region.
The next-generation sequencing market in Europe is expected to hold the second-largest revenue share due to the presence of some of the leading next-generation sequencing technology companies and an educated population inclined on the advancement of next-generation sequencing technology. Though diverse regulations and a fragmented NGS market might restrain the growth of the market in the region, favorable funding scenario and immense support for scientific research would augment the next-generation sequencing market in the region.
The next-generation sequencing market share in Asia-Pacific is projected to witness expansion over the coming years due to growing demand for advanced technology and access to enhanced treatment facilities, better adoption of advanced genomics, an increase in disposable income, and rising investments in diverse treatment options by pharmaceutical companies.
Due to lack of technical knowledge, an underdeveloped healthcare sector, and poor medical facilities the next-generation sequencing market in the Middle East and Africa is expected to garner the smallest share.
Competitive Landscape
Some of the Key Players in the Global Next-Generation Sequencing Market Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Inc., BGI, PerkinElmer, Agilent Technologies, QIAGEN N. V., Macrogen Inc., Oxford Nanopore Technologies, Ltd., and Eurofins Scientific.
Industry News
Recently, Thermo Fisher Scientific launched its Ion Torrent Genexus System, the first fully integrated, next-generation sequencing platform that delivers results economically in a single day. This turnkey solution is designed to enable local hospitals to adopt NGS testing.
According to a study published in Clinical Lung Cancer local hospitals are severely challenged when it comes to providing NGS-based genomic testing at present even though hospitals are where most patients are treated. Due to limitations to NGS adoption, such as product complexity and cost, the vast majority of local molecular laboratories rely on single-gene tests. Some laboratories even have to outsource testing for more comprehensive NGS analysis as single-gene tests fail to provide a complete genomic profile of a tumor. Ion Torrent Genexus System is expected to solve many of the problems faced by hospitals when it comes to gene testing thus increasing growth scope for next-generation sequencing.
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/next-generation-sequencing-market-6354
Next Generation Sequencing Market OverviewThere are various diseases that have their roots in genetics such as cancer, diabetes, Alzheimer’s, arthritis, heart disease etc.
To discover viable treatment to these diseases, researchers are looking to discern how genes work.
Next generation sequencing market has been gaining impetus due to the fact that next-generation sequencing is integral to field of genomics.
The NGS technologies are implemented for several applications, including whole genome sequencing, de novo assembly sequencing, resequencing, and transcriptome sequencing at the DNA or RNA level.
The successful application of next-generation sequencing can lead to predicting of genes, protein coding regions, and pathways.Illumina, Helicos Biosciences, Thermo Fisher Scientific, Roche, Pacific Bioscience, ABI Life Technologies, and Oxford Nanopore are some of the companies that are implementing different NGS technologies which in turn will augment global next generation sequencing market which is estimated to reach a massive market valuation by 2023.Next Generation Sequencing Market Segmentation:The next generation sequencing market has been classified by technology, service and product, application, and end-user.By technology, next generation sequencing market has been segmented as whole genome sequencing, methyl sequencing, whole exome sequencing, targeted resequencing, CHIP sequencing, RNA sequencing and de novo sequencing.By service & product, next generation sequencing market has been segmented as consumables, sample preparation, sequencing services and platforms and services for platforms.By application, NGS market has been segmented as genetic screening, drug discovery, diagnostics, agriculture and animal research and others.End-users segmentation of the next generation sequencing market includes academic institutes and research centers, pharmaceutical and biotechnology companies, hospitals and clinics, and other end-users.Next Generation Sequencing Market Regional Analysis:Owing to rising number of funds being granted for research into genomics and initiatives adopted by the government to rein in cases of genetically occurring diseases and demand to improve the healthcare sector is estimated to augment the growth of the next generation sequencing market in North America.
Increased competition among market players as well as acquisitions and mergers are expected to drive the growth of the market in the region.Next generation sequencing market in Europe is expected to hold the second largest revenue share due to the presence of some of the leading next-generation sequencing technology companies and an educated population inclined on the advancement of next-generation sequencing technology.
The statistical surveying report on the global Direct-to-consumer Genetic Testing Market has been presented by using professional or expert knowledge through standard and modified research approaches and forecasts.
The yearly forecast and predication for the years 2020 to 2025 have been enclosed by the report along with comprehensive analysis for all market segments and regions.
The statistical data derived from authentic resources and assisted by industry experts.
It likewise assesses the market by evaluating market elements, including drivers, restraints, opportunities, threats, challenges, growth prospects, and other market elements.The global direct-to-consumer genetic testing market report presents a complete research-based study of the industry including details such as company shares, forecast data, in-depth analysis and an outlook of the market on a worldwide platform.
For a thorough understanding, the report also offers market segmentation and regional analysis for the forecast period from 2020 to 2025.Get FREE Sample Report Copy @ https://www.decisiondatabases.com/contact/download-sample-43122Direct-to-consumer (DTC) genetic testing is a type of genetic test that is accessible directly to the consumer without having to go through a health care professional.
Usually, to obtain a genetic test, health care professionals (such as doctors) acquire their patient's permission and then order the desired test.
Ltd is a clinical genetic laboratory that specializes in prenatal and postnatal diagnosis, biochemical screening, BRCA screening ,Oncology, Personalized Genomics, Routine testing to advanced genetic screening solutions all under one roof.
We are headquartered in Gurgaon and provide our services in Chandigarh, Lucknow, Fridabad, Haryana, Noida, Delhi NCR, Mumbai, Chennai, Gujarat, Ranchi, Kerela, Kolkata, Bangalore, Goa, Hyderabad, Pune.
Call Now for Booking 18001214030 | [email protected] test, genetic test for weight loss, genetic testing, routine test, testing lab, dna genetic testing lab, dna genetic testing, genetic testing in delhi
